The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(5-(4-Fluorobenzylidene)-2,4-dioxothiazolidin-3-yl)-N-(4-chlorophenyl)acetamide ID: ALA4554145
PubChem CID: 1583408
Max Phase: Preclinical
Molecular Formula: C18H12ClFN2O3S
Molecular Weight: 390.82
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(CN1C(=O)S/C(=C\c2ccc(F)cc2)C1=O)Nc1ccc(Cl)cc1
Standard InChI: InChI=1S/C18H12ClFN2O3S/c19-12-3-7-14(8-4-12)21-16(23)10-22-17(24)15(26-18(22)25)9-11-1-5-13(20)6-2-11/h1-9H,10H2,(H,21,23)/b15-9-
Standard InChI Key: HVSNYQQANCAZFS-DHDCSXOGSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
26.2655 -24.4017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0868 -24.4017 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.3453 -23.6209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6782 -23.1346 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
26.0154 -23.6209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2339 -23.3687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0637 -22.5653 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6767 -22.0150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5028 -21.2123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7207 -20.9594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1123 -21.5113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2852 -22.3119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1229 -23.3694 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.5705 -25.0675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3875 -24.9831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8670 -25.6489 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.6840 -25.5603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1635 -26.2268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9797 -26.1428 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3137 -25.3919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8295 -24.7242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0150 -24.8115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7207 -24.2328 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.7843 -25.0664 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.1264 -25.3067 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
24.5488 -20.1605 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
3 13 2 0
2 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
15 23 2 0
1 24 2 0
20 25 1 0
10 26 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 390.82Molecular Weight (Monoisotopic): 390.0241AlogP: 4.15#Rotatable Bonds: 4Polar Surface Area: 66.48Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.15CX Basic pKa: ┄CX LogP: 3.73CX LogD: 3.73Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.80Np Likeness Score: -2.35
References 1. Hassan GS, Georgey HH, Mohammed EZ, Omar FA.. (2019) Anti-hepatitis-C virus activity and QSAR study of certain thiazolidinone and thiazolotriazine derivatives as potential NS5B polymerase inhibitors., 184 [PMID:31604164 ] [10.1016/j.ejmech.2019.111747 ]